Brief: Assembly Biosciences Updates Pipeline Strategy

Assembly Biosciences

25/02/2021 21:06

Feb 25 (Reuters) - Assembly Biosciences Inc  ASMB.O :
    * ASSEMBLY BIOSCIENCES UPDATES PIPELINE STRATEGY, FOCUSING
ON
FINITE AND CURATIVE THERAPIES FOR CHRONIC HEPATITIS B VIRUS
INFECTION
    * ASSEMBLY BIOSCIENCES INC - EXTENDS CASH RUNWAY INTO 2023

Source text for Eikon:  ID:nGNX53dk9t 
Further company coverage:  ASMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))